Best TWAS P=4.12e-09 · Best GWAS P=1.44e-07 conditioned to 0.881
| # | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 | The Cancer Genome Atlas | Breast Invasive Carcinoma | FES | 0.06 | 0.05 | blup | 46 | 0.07 | 7.4e-14 | 5.3 | -5.9 | 4.1e-09 | -0.88 | 0.00 | 0.99 | TRUE |
| 9 | The Cancer Genome Atlas | Prostate Adenocarcinoma | FES | 0.12 | 0.09 | lasso | 5 | 0.08 | 4.1e-09 | 5.3 | -5.5 | 2.8e-08 | -0.95 | 0.00 | 1.00 | FALSE |
| 3 | GTEx | Cells Transformed fibroblasts | FES | 0.28 | 0.17 | enet | 21 | 0.20 | 2.8e-15 | 5.3 | -5.5 | 3.1e-08 | -0.92 | 0.00 | 1.00 | FALSE |
| 4 | GTEx | Lung | FES | 0.24 | 0.07 | lasso | 6 | 0.05 | 5.1e-05 | 4.8 | -5.5 | 5.0e-08 | -0.90 | 0.00 | 0.99 | FALSE |
| 10 | The Cancer Genome Atlas | Stomach Adenocarcinoma | FES | 0.04 | 0.01 | blup | 46 | 0.02 | 1.7e-02 | 4.6 | -5.4 | 6.8e-08 | -0.75 | 0.01 | 0.45 | FALSE |
| 7 | The Cancer Genome Atlas | Lung Adenocarcinoma | FES | 0.05 | 0.04 | lasso | 2 | 0.04 | 2.2e-05 | 5.3 | -5.3 | 9.0e-08 | -0.95 | 0.00 | 0.99 | FALSE |
| 11 | The Cancer Genome Atlas | Thyroid Carcinoma | FES | 0.30 | 0.30 | lasso | 7 | 0.32 | 1.3e-31 | 5.0 | -5.3 | 1.1e-07 | -0.95 | 0.00 | 1.00 | FALSE |
| 6 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | FES | 0.06 | 0.02 | blup | 46 | 0.02 | 2.4e-02 | 5.3 | -5.2 | 1.5e-07 | -0.81 | 0.00 | 0.84 | FALSE |
| 2 | GTEx | Artery Tibial | FES | 0.16 | 0.04 | lasso | 5 | 0.05 | 4.8e-05 | 4.8 | -5.2 | 1.9e-07 | -0.89 | 0.00 | 0.99 | FALSE |
| 1 | GTEx | Adipose Visceral Omentum | FES | 0.21 | 0.09 | lasso | 5 | 0.05 | 1.3e-03 | 5.3 | -5.2 | 2.0e-07 | -0.99 | 0.00 | 0.99 | FALSE |
| 8 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | FES | 0.13 | 0.16 | lasso | 2 | 0.14 | 6.1e-10 | 5.3 | -5.2 | 2.5e-07 | -0.99 | 0.00 | 1.00 | FALSE |